Other languages CURE BIOT OTC Markets

Equities

CUBT

US23128N2071

Market Closed - OTC Markets Other stock markets 02:16:52 2024-05-31 pm EDT			5-day change	1st Jan Change
0.019 ^USD	-1.04%		-1.30%	-10.80%

May. 06	Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	May. 06
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	Mar. 22
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	Jan. 08
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	Nov. 25
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors	23-10-31
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	23-09-07
Curative Biotechnology, Inc. Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	23-06-07
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	23-06-06
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation	23-05-24
Curative Biotechnology, Inc. Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	23-01-05
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	23-01-05
Curative Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-16
Curative Biotechnology, Inc. has filed an IPO in the amount of $7.999998 million.	22-11-07
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $8 million.	22-10-31
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	22-09-27
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	22-09-27
Curative Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-01
Curative Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-06-29
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	22-06-16
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	22-06-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CURE BIOT OTC Markets

Equities

CUBT

US23128N2071

Other languages

Filters